Skip to content

Maternal and developmental toxicity of ayahuasca in Wistar rats

Carolina Dizioli Rodrigues de Oliveira, Camila Queiroz Moreira, Lílian Rose Marques de Sá, Helenice de Souza Spinosa, Maurı́cio Yonamine

Birth Defects Research Part B Developmental and Reproductive Toxicology May 11, 2010 DOI: 10.1002/bdrb.20244 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Animal experiment Peer reviewed
Population Pregnant Wistar rats
Intervention Ayahuasca
Dose equivalent typical dose (TD) administered to humans, five-fold TD and 10-fold TD
Duration Gestational period (6–20 days)
Topics Ayahuasca
Keywords Developmental toxicity Fetus Physiology Gestation Acute toxicity Pregnancy Body weight Teratology
Citations 44
Key findings Ayahuasca exposure during gestation caused dose-dependent maternal and developmental toxicity in rats, including reduced maternal weight gain, fetal visceral and skeletal abnormalities, and decreased fetal body weight at the highest dose.

Abstract

Abstract

Introduction: Ayahuasca is a psychotropic plant beverage initially used by shamans throughout the Amazon region during traditional religious cult. In recent years, ayahuasca has also been used in ceremonies of a number of modern syncretic religious groups, including pregnant women. However, no documented study has been performed to evaluate the risk of developmental toxicity of ayahuasca.

Methods: In the present work, maternal and developmental toxicity was evaluated in Wistar rats. Ayahuasca was administered to pregnant rats in three different doses [the equivalent typical dose (TD) administered to humans, five‐fold TD and 10‐fold TD] during the gestational period (6–20 days).

Results: Dams treated with the highest ayahuasca dose showed maternal toxicity with decrease of weight gain and food intake. Visceral fetal findings were observed in all treatment groups. Skeletal findings were observed in the intermediate‐ and high‐dose groups. The fetuses deriving from the highest dose group also presented a decrease in body weight.

Conclusions: From these results, it is possible to conclude that there is a risk of maternal and developmental toxicity following ayahuasca exposure and that the level of toxicity appears to be dose‐dependent. Birth Defects Res (Part B) 89:207–212, 2010. © 2010 Wiley‐Liss, Inc.

Comparable studies

Other preclinical and animal studies on ayahuasca, most cited first.

Study Year Design Participants
Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca Eight ayahuasca samples from Peru and several Banisteriopsis caapi cultivars 1984 Qualitative and quantitative chemical analysis with in vitro assay
The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro Progenitor cells from subventricular and subgranular zones of adult mice brains 2017 In vitro experimental study
N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo Mice 2020 In vitro and in vivo experimental study
Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat Female Wistar rats 2015 Observational cohort
Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice Mice 2015 Experimental study

Citations in the library

Cited by 30

and 25 more in the library

Cites 8

and 3 more in the library

Explore topics